You are here

Home

Clinical Trials: Brain Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, January 26, 2023 - 12:00
Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke
Condition:   Ischemic Stroke
Intervention:   Biological: MSC
Sponsor:   Shanghai IxCell Biotechnology Co., LTD
Not yet recruiting
Posted: Thursday, January 26, 2023 - 12:00
Clinical Study on the Efficacy of Natural Stem Cell Mobilizers on Parkinson Disease
Condition:   Parkinson Disease
Intervention:   Dietary Supplement: StemRegen product
Sponsor:   Sociedad Española de Medicina Regenerativa y Terapia Celular
Recruiting
Posted: Thursday, January 26, 2023 - 12:00
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early- to Moderate Stage MSA
Conditions:   Multiple System Atrophy;   MSA - Multiple System Atrophy
Interventions:   Drug: hOMSC300;   Other: Sham Procedure
Sponsor:   Cytora Ltd.
Recruiting
Posted: Thursday, January 19, 2023 - 12:00
Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease.
Condition:   Idiopathic Parkinson's Disease
Intervention:   Biological: hAESCs
Sponsors:   Shanghai East Hospital;   Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Not yet recruiting
Posted: Wednesday, December 28, 2022 - 12:00
RB-ADSC for Treatment of Mild to Moderate Alzheimer's Disease
Condition:   Alzheimer Disease
Intervention:   Biological: RB-ADSC
Sponsor:   Regeneration Biomedical, Inc.
Not yet recruiting
Posted: Friday, December 2, 2022 - 12:00
A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease
Condition:   Parkinson Disease
Intervention:   Biological: STEM-PD
Sponsors:   Region Skane;   Lund University;   Cambridge University Hospitals NHS Foundation Trust;   University of Cambridge
Not yet recruiting
Posted: Thursday, September 15, 2022 - 12:00
A Multi-center, Randomized, Double-blind, Phase 2 Study, Evaluating JCPyV-specific T Cell Therapy for the Treatment of PML
Condition:   Progressive Multifocal Leukoencephalopathy
Intervention:   Biological: CE-VST01-JC
Sponsor:   Cellevolve Bio Inc
Not yet recruiting
Posted: Wednesday, August 24, 2022 - 12:00
A Multicenter, Randomized Trial to Assess Safety, and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Conditions:   Hypoxic-Ischemic Encephalopathy;   Neonatal Asphyxia;   Neonatal Encephalopathy
Interventions:   Drug: Normal Saline along with standard treatment;   Drug: Sovateltide along with standard treatment
Sponsor:   Pharmazz, Inc.
Not yet recruiting
Posted: Thursday, August 11, 2022 - 12:00
Exercise Reset for Concussion in a Military Environment
Condition:   Brain Concussion
Intervention:   Behavioral: Aerobic Exercise
Sponsors:   State University of New York at Buffalo;   United States Department of Defense;   Children's Hospital of Philadelphia;   University of Pennsylvania;   University of North Carolina, Chapel Hill;   Geneva Foundation;   Quadrant Biosciences Inc.;   Center for Neuroscience and Regenerative Medicine (CNRM);   Axon Medical Technologies LLC
Not yet recruiting
Posted: Tuesday, June 28, 2022 - 12:00
Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.
Condition:   Parkinson's Disease
Interventions:   Biological: hAESCs treatment;   Biological: placebo (saline)
Sponsors:   Shanghai East Hospital;   Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Not yet recruiting

Pages